RCOG Guidelines
- Management of Endometrial Hyperplasia – GTG No. 67 – February 2016
- Guidelines for the Diagnosis and Management of Vulval Carcinoma – RCOG – May 2014
NICE Guidelines
- Ovarian cancer – The recognition and initial management of ovarian cancer – NICE CG122 – Updated October 2023
- Testing strategies for Lynch syndrome in people with endometrial cancer – NICE DG42 – October 2020
RCOG – Other Publications
- Management of Female Malignant Ovarian Germ Cell Tumours – RCOG Scientific Impact Paper No.52 – November 2016
- Ovarian Cancer, Optimum Surgery in Advanced-stage – RCOG Scientific Impact Paper 25 – June 2011
- Progress in Cervical Screening – RCOG Scientific Impact Paper 7 – March 2016
- Reproductive Outcomes after Local Treatment for Preinvasive Cervical Disease – RCOG Scientific Impact Paper No.21 – July 2016
- Targeted therapies for the management of ovarian cancer – RCOG Scientific Impact Paper 12 – September 2013
- The Use of Biomarkers to Stratify Surgical Care in Women with Ovarian Cancer – RCOG Scientific Impact Paper No. 69 – May 2022
British Gynaecological Cancer Society Guidelines
- Vulval Cancer – Updated January 2024
- Cervical Cancer – May 2020
- BGCS Ovarian, Tubal and Primary Peritoneal Cancer Guideline – Updated September 2024
- BGCS Uterine Cancer Guidelines: Recommendations for Practice – November 2021
- BAGP/BGCS 2021 FIGO Staging System for Vulvar Cancer: Summary and comparison with 2009 FIGO Staging System – November 2021
- Sentinel Consensus Document for Vulval, Endometrial and Cervical Cancer BGCS
- British Gynaecological Cancer Society and British Menopause Society guidelines – Management of menopausal symptoms following treatment of gynaecological cancer – August 2024
- BMS/BGCS/BSGE joint guidance on management of women with unscheduled bleeding on HRT – May 2024
- British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United Kingdom – March 2024
Miscellanous
- FIGO Ovarian Cancer Staging – 2014
- FIGO staging for carcinoma of the vulva: 2021 revision
- FIGO Staging for Carcinoma of the Vulva, Cervix, Endometrium, and Sarcomas – 2014
- Cervical screening: programme and colposcopy management
TOG Articles
- Diagnosing adnexal tumours before surgery – a critical appraisal of recent evidence – TOG 2015;17:163–71
- Management of borderline ovarian tumours – TOG 2012;14:115–120
- Pelvic exenteration for recurrent gynaecological cancer after radiotherapy – TOG 2017;19:109–18
- Surgical management of bowel obstruction in gynaecological cancer – TOG 2017;19:63–70
- The fallopian tube as the origin of non-uterine pelvic high-grade serous carcinoma – TOG 2016;18:143–52
- The molecular and genetic basis of inherited cancer risk in gynaecology – TOG 2015;17:233–41
- Update on chemotherapy in gynaecological cancers – TOG 2016;18:182–8
- Update on radiotherapy in gynaecological malignancies – TOG 2017;19:29–36
- Endometrial cancer and obesity – TOG 2019;21:237-245
- Hormone replacement therapy following treatment of gynaecological malignancies – TOG 2019;21:291-298
- Raised CA125 – what we actually know… – TOG 2021;23:21-27
- Lynch syndrome for the gynaecologist – TOG 2021;23:9-20
- Detecting endometrial cancer – TOG 2021;23:103-112
- Cervical cancer in pregnancy: diagnosis, staging and treatment – TOG 2022;24:31-39
- Paraneoplastic syndrome associated with gynaecological malignancy: a review of the evidence – TOG 2022;24:137-142
- Human papillomavirus-independent cervical cancer and its precursor lesions – TOG 2023:25 47-58
- Sentinel lymph node mapping in the modern management of gynaecological malignancy – TOG 2023;25: 210-219
- Recent trends in molecular testing and maintenance targeted therapies in ovarian cancer – TOG 2023;25: 220-228
- Endometriosis as a risk factor for ovarian cancer: an update on screening, risk reduction, treatment and prognosis – TOG 2024:26 189-196
- Hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of ovarian cancer – TOG 2024:26 76-83
- A review of the global inequalities in the management of gynaecological cancers – TOG 2025;27:29-36
- Cervical cancer elimination: what, how and WHO? – TOG 2025;27:241-251